Pictet Asset Management
RAPP

Pictet Asset Management’s Rapport Therapeutics RAPP Stock Holding History

Pictet Asset Management’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+5,198
New +$191K ﹤0.01% 1951

Other funds holding RAPP

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CPW
Catalyst Private Wealth San Mateo, California $207M AUM 11.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Pictet Asset Management's RAPP Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 5,198 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1951 among its holdings.

24 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Pictet Asset Management held 5,198 shares of Rapport Therapeutics worth $217K as of Q2 2026.
  • Rapport Therapeutics was a new Pictet Asset Management position in Q2 2026.
  • Rapport Therapeutics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1951 holding.
  • 24 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.